The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PPC, ENPH and CEMI

NEW YORK, NY / ACCESSWORE / July 13, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Pilgrim's Pride Corporation (NASDAQ:PPC)

Investors Affected: February 9, 2017 - June 3, 2020

A class action has commenced on behalf of certain shareholders in Pilgrim's Pride Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company and its executives had participated in an illegal antitrust conspiracy to fix prices and rig bids from at least as early as 2012 and continuing through at least early 2017; (2) the Company received competitive advantages, which persisted during the Class Period, from its anticompetitive conduct; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/pilgrims-pride-corporation-loss-submission-form/?id=7931&from=1

Enphase Energy, Inc. (NASDAQ:ENPH)

Investors Affected: February 26, 2019 - June 17, 2020

A class action has commenced on behalf of certain shareholders in Enphase Energy, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) its revenues, both U.S. and international, were inflated; (2) the Company engaged in improper deferred revenue accounting practices; (3) the Company's reported base points expansion in gross margins were overstated; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/enphase-energy-inc-loss-submission-form/?id=7931&from=1

Chembio Diagnostics, Inc. (NASDAQ:CEMI)

Investors Affected: March 12, 2020 - June 16, 2020

A class action has commenced on behalf of certain shareholders in Chembio Diagnostics, Inc. According to the filed complaint, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Chembio's stock price and operated as a fraud or deceit by misrepresenting the efficacy of the Company's Dual Path Platform ("DPP") COVID-19 test. Defendants allegedly achieved this by making false statements about Chembio's DPP COVID-19 test, although they knew or at least recklessly disregarded that there were material performance concerns with the test. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Chembio stock fell precipitously as the prior artificial inflation came out of Chembio's stock price.

Shareholders may find more information at https://securitiesclasslaw.com/securities/chembio-diagnostics-inc-loss-submission-form/?id=7931&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/597355/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-PPC-ENPH-and-CEMI

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.